Exhalation delivery system reduces inflammation of nasal cavity and symptoms of chronic sinusitis Dr. Kamal Kant Kohli17 Jun 2022 7:30 PM ISTAn exhalation delivery system that uses fluticasone propionate nasal spray may reduce symptoms of chronic sinusitis and local inflammation of the...
Roflumilast foam useful in patients with moderate to severe seborrheic dermatitis, reveals phase 3 trial Dr. Kamal Kant Kohli12 Jun 2022 7:30 PM ISTWESTLAKE VILLAGE, Calif: Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing meaningful...
New drug combination improves survival for some with lung cancer Dr. Kamal Kant Kohli4 Jun 2022 6:45 AM ISTPatients with advanced non-small cell lung cancer whose cancer had progressed on previous immunotherapy lived significantly longer when subsequently...
Evinacumab significantly lowers LDL C in kids with homozygous familial hypercholesterolemia Dr. Kamal Kant Kohli1 Jun 2022 10:00 AM ISTEvinacumab is a fully-human monoclonal antibody that binds to and blocks the function of angiopoietin-like 3 (ANGPTL3). According to findings from a...
Investigational JAK inhibitor found safe, effective in moderate to severe alopecia areata in phase 3 study Dr. Kamal Kant Kohli26 May 2022 8:00 PM ISTAlopecia areata is an autoimmune disorder that results in patchy or complete scalp hair loss. CTP-543 is an investigational oral selective inhibitor...
FDA Approves tapinarof cream- first nonsteroidal treatment for plaque psoriasis Dr. Kamal Kant Kohli26 May 2022 10:00 AM ISTThe Food and Drugs Administration has approved Vtama cream for treating plaque psoriasis with varying severity. The approval was announced by...
Dasiglucagon cuts IV glucose requirement in Pediatric Patients with Congenital Hyperinsulinism: Phase 3 Trial Dr. Kamal Kant Kohli20 May 2022 7:45 PM ISTreducing the requirement for IV glucose
Phase 3 trial of nasal spray for treatment of anxiety disorders underway Dr. Kamal Kant Kohli20 April 2022 9:00 AM ISTVistaGen Therapeutics and AffaMed Therapeutics have announced a global phase 3 trial to assess the efficacy, safety and tolerability of a fast-acting...
Novel treatment for sciatica provides pain relief beyond one month: C.L.E.A.R. trial Medha Baranwal7 April 2022 9:00 AM ISTUSA: Findings released from phase 3 C.L.E.A.R. trial evaluating safety and treatment of SP-102 (injectable dexamethasone sodium phosphate viscous gel)...
